wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38042401-239EE449-F95F-4A2D-B852-4634A198023B
Q38042401-239EE449-F95F-4A2D-B852-4634A198023B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38042401-239EE449-F95F-4A2D-B852-4634A198023B
Differences in drug approval processes of 3 regulatory agencies: a case study of gemtuzumab ozogamicin.
P2860
Q38042401-239EE449-F95F-4A2D-B852-4634A198023B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38042401-239EE449-F95F-4A2D-B852-4634A198023B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a0287424776543ddc04c65e759e053e5e1dd3a6
P2860
Acute myeloid leukemia stem cells and CD33-targeted immunotherapy